Literature DB >> 12805430

Respiratory syncytial virus nucleoprotein-specific cytotoxic T-cell epitopes in a South African population of diverse HLA types are conserved in circulating field strains.

Marietjie Venter1, Michael Rock, Adrian J Puren, Caroline T Tiemessen, James E Crowe.   

Abstract

This study identifies memory cytotoxic T lymphocyte (CTL) epitopes to respiratory syncytial virus (RSV) in healthy South African adults and demonstrates the conservation of those epitopes in circulating field strains of RSV in South Africa. Thirty-seven healthy adults from a population with diverse HLA backgrounds were screened by gamma interferon (IFN-gamma) enzyme-linked immunospot for memory CTL activity in response to overlapping peptides representing the complete nucleoprotein (N) of RSV. Responses of more than 40 spot-forming cells/million cells were detectable in 21 individuals. The significant responses were further characterized, and 14-mer peptides were identified that induced cytolytic activity. Fine mapping of peptides with the highest cytolytic activity identified an HLA-B(*)08-restricted RSV-specific CTL epitope. The extended 14-mer peptide containing this epitope also induced lysis in the context of A(*)02-restricted target cells in some individuals. These HLA types are common in the target population; thus, the epitope is useful for studies of CTL responses to RSV in humans. The epitope was detected in healthy adults, reflecting the response generated in the course of previous natural RSV infection. We obtained a large panel of naturally occurring isolates of RSV to determine whether there was evidence of escape from CTL activity in circulating strains. We found that this epitope and a previously identified B(*)07-restricted N protein epitope were conserved in RSV field strains representing the diversity of circulating genotypes. This work suggests that escape from CTL activity is not common for this acute respiratory infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805430      PMCID: PMC164818          DOI: 10.1128/jvi.77.13.7319-7329.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  SYFPEITHI: database for MHC ligands and peptide motifs.

Authors:  H Rammensee; J Bachmann; N P Emmerich; O A Bachor; S Stevanović
Journal:  Immunogenetics       Date:  1999-11       Impact factor: 2.846

2.  Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.

Authors:  P J Goulder; C Brander; K Annamalai; N Mngqundaniso; U Govender; Y Tang; S He; K E Hartman; C A O'Callaghan; G S Ogg; M A Altfeld; E S Rosenberg; H Cao; S A Kalams; M Hammond; M Bunce; S I Pelton; S A Burchett; K McIntosh; H M Coovadia; B D Walker
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

3.  Antigenic drift in the influenza A virus (H3N2) nucleoprotein and escape from recognition by cytotoxic T lymphocytes.

Authors:  J T Voeten; T M Bestebroer; N J Nieuwkoop; R A Fouchier; A D Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

4.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

5.  Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

Authors:  R A Karron; D A Buonagurio; A F Georgiu; S S Whitehead; J E Adamus; M L Clements-Mann; D O Harris; V B Randolph; S A Udem; B R Murphy; M S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  Serological and genetic characterisation of bovine respiratory syncytial virus (BRSV) indicates that Danish isolates belong to the intermediate subgroup: no evidence of a selective effect on the variability of G protein nucleotide sequence by prior cell culture adaption and passages in cell culture or calves.

Authors:  L E Larsen; A Uttenthal; P Arctander; K Tjørnehøj; B Viuff; C Røntved; L Rønsholt; S Alexandersen; M Blixenkrone-Møller
Journal:  Vet Microbiol       Date:  1998-08-15       Impact factor: 3.293

Review 7.  Respiratory syncytial virus infection in tropical and developing countries.

Authors:  M W Weber; E K Mulholland; B M Greenwood
Journal:  Trop Med Int Health       Date:  1998-04       Impact factor: 2.622

8.  In vivo dynamics of anti-viral CD8 T cell responses to different epitopes. An evaluation of bystander activation in primary and secondary responses to viral infection.

Authors:  K Murali-Krishna; J D Altman; M Suresh; D Sourdive; A Zajac; R Ahmed
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

9.  Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter.

Authors:  U J Buchholz; S Finke; K K Conzelmann
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Viral escape by selection of cytotoxic T cell-resistant variants in influenza A virus pneumonia.

Authors:  G E Price; R Ou; H Jiang; L Huang; D Moskophidis
Journal:  J Exp Med       Date:  2000-06-05       Impact factor: 14.307

View more
  19 in total

1.  Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses.

Authors:  Guillermina A Melendi; Dowd Bridget; Ana C Monsalvo; Federico F Laham; Patricio Acosta; Maria Florencia Delgado; Fernando P Polack; Pablo M Irusta
Journal:  Virus Genes       Date:  2010-11-04       Impact factor: 2.332

2.  Serologic cross-reactions between nucleocapsid proteins of human respiratory syncytial virus and human metapneumovirus.

Authors:  Yange Zhang; Jan Pohl; W Abdullah Brooks; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

3.  Tissue-specific regulation of CD8+ T-lymphocyte immunodominance in respiratory syncytial virus infection.

Authors:  Sujin Lee; Scott A Miller; David W Wright; Michael T Rock; James E Crowe
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  Gold nanorod vaccine for respiratory syncytial virus.

Authors:  John W Stone; Natalie J Thornburg; David L Blum; Sam J Kuhn; David W Wright; James E Crowe
Journal:  Nanotechnology       Date:  2013-06-25       Impact factor: 3.874

5.  Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays.

Authors:  Michael T Rock; Brett A McKinney; Sandra M Yoder; Catherine E Prudom; David W Wright; James E Crowe
Journal:  J Immunol Methods       Date:  2011-08-11       Impact factor: 2.303

6.  Amino acid variation within the fusion protein of respiratory syncytial virus subtype A and B strains during annual epidemics in South Africa.

Authors:  Elizabeth Agenbach; Caroline T Tiemessen; Marietjie Venter
Journal:  Virus Genes       Date:  2005-03       Impact factor: 2.332

7.  Enhancement of the CD8+ T cell response to a subdominant epitope of respiratory syncytial virus by deletion of an immunodominant epitope.

Authors:  Hoyin Mok; Sujin Lee; David W Wright; James E Crowe
Journal:  Vaccine       Date:  2008-07-26       Impact factor: 3.641

8.  Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells.

Authors:  Susana Infantes; Elena Lorente; Eilon Barnea; Ilan Beer; Juan José Cragnolini; Ruth García; Fátima Lasala; Mercedes Jiménez; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2010-01-15       Impact factor: 5.911

9.  Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells.

Authors:  Pablo F Céspedes; Susan M Bueno; Bruno A Ramírez; Roberto S Gomez; Sebastián A Riquelme; Christian E Palavecino; Juan Pablo Mackern-Oberti; Jorge E Mora; David Depoil; Catarina Sacristán; Michael Cammer; Alison Creneguy; Tuan H Nguyen; Claudia A Riedel; Michael L Dustin; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-23       Impact factor: 11.205

Review 10.  Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

Authors:  Matthew R Olson; Steven M Varga
Journal:  Expert Rev Vaccines       Date:  2008-10       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.